Systemic Reluctance: Medical Inertia and the Pharmaceutical Industry’s Influence on Long COVID Treatment

Abstract Despite the global burden of Long COVID, the medical profession has demonstrated a striking reluctance to engage in consistent diagnosis, treatment, and research. This article explores the multifactorial roots…[...]

Read More

Cortisol Dysregulation in Long COVID: A Neuroendocrine Perspective on Persistent Sequelae

John Murphy, The COVID 19 Long-haul Foundation Abstract Long COVID, a multifaceted syndrome emerging after acute SARS-CoV-2 infection, has challenged conventional models of post-viral recovery. Among its many physiological disruptions,…[...]

Read More